Search - tctmd.com

Displaying 121 - 140 of 476

Sort: Relevancy | Date

Presentation NY Valves 2024

Patient and Device Selection Following Commercial Approval of TTVI Devices: European Perspectives

Presenter: Jörg Hausleiter

June 05, 2024

Presentation NY Valves 2024

Transcatheter Tricuspid Valve-in-Valve Implantation for Degenerative Surgical Bio-Prosthesis THV

Presenter: Praveen Chandra

June 05, 2024

Presentation NY Valves 2024

Pro-T-TEER: Safety Comes First, Risk of Replacement Outweighs the Benefits!

Presenter: Sam Dawkins

June 05, 2024

Presentation NY Valves 2024

Pro-TTVR: Total TR Resolution Must be a Goal and is a Key Factor Impacting Long-Term Outcomes

Presenter: Stephan Windecker

June 05, 2024

Presentation NY Valves 2024

Case Presentation: A Non-Surgical Patient With Complex Tricuspid Valve Disease

Presenter: Alexander Lauten

June 05, 2024

Presentation NY Valves 2024

Lifetime Management of Transcatheter Tricuspid Valve Replacement: Patient and Device Considerations

Presenter: Gabriel Sayer

June 05, 2024

Presentation NY Valves 2024

Pre-Existing and New CIED: The Achilles Heel of Transcatheter Tricuspid Valve Replacement?

Presenter: Laurence Epstein

June 05, 2024

Presentation NY Valves 2024

An Objective Measure of Pacemaker Slack Grade for Transcatheter Tricuspid Valve Intervention

Presenter: Craig Basman

June 05, 2024

Presentation NY Valves 2024

Patient Selection in Transcatheter Tricuspid Valve Replacement: How to Best Use Multimodality Imaging?

Presenter: Anna Sannino

June 05, 2024

Presentation NY Valves 2024

What Have the Studies Taught Us About Transcatheter Tricuspid Valve Replacement – The Good, the Bad, and the Ugly

Presenter: Azeem Latib

June 05, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

News Daily News

FDA Approves TriClip TEER Device for Tricuspid Repair

L.A. McKeown

April 02, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

Michael O'Riordan

February 13, 2024

News Daily News

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

Michael O'Riordan

February 09, 2024

News Daily News

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

L.A. McKeown

February 02, 2024

News Daily News

Top Structural Heart News of 2023

Todd Neale

January 02, 2024

Advertisement

Patient and Device Selection Following Commercial Approval of TTVI Devices: European Perspectives

Transcatheter Tricuspid Valve-in-Valve Implantation for Degenerative Surgical Bio-Prosthesis THV

Pro-T-TEER: Safety Comes First, Risk of Replacement Outweighs the Benefits!

Pro-TTVR: Total TR Resolution Must be a Goal and is a Key Factor Impacting Long-Term Outcomes

Case Presentation: A Non-Surgical Patient With Complex Tricuspid Valve Disease

Lifetime Management of Transcatheter Tricuspid Valve Replacement: Patient and Device Considerations

Pre-Existing and New CIED: The Achilles Heel of Transcatheter Tricuspid Valve Replacement?

An Objective Measure of Pacemaker Slack Grade for Transcatheter Tricuspid Valve Intervention

Patient Selection in Transcatheter Tricuspid Valve Replacement: How to Best Use Multimodality Imaging?

What Have the Studies Taught Us About Transcatheter Tricuspid Valve Replacement – The Good, the Bad, and the Ugly

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

FDA Approves TriClip TEER Device for Tricuspid Repair

Evoque and Patisiran: A Tale of Two Regulatory Journeys

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Debating the Role of T-TEER in the Sickest Patients

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

Top Structural Heart News of 2023

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content